Skip to content
Open access

Successes in Reducing Cause-Specific Mortality, United States, 2000-2019.

Aug 2026 · Public health reports (1974) · pp. 333549261477725 · 0 citations · 36 references
Medicine

TL;DR

Successful public health strategies have continued to reduce mortality from somatic "below-the-neck" causes, but parallel strategies are needed to address mental health, substance use, health behaviors, and healthy aging.

Abstract

Objective

Major successes in improving health in the United States during the past century have occurred as our nation moved through the epidemiologic transition from high infectious disease mortality to predominantly chronic disease mortality. The objective of this study was to identify successes in improving America's health in the first 2 decades of the 21st century.

Methods

We identified leading causes of death among US adults with age-adjusted mortality rates that declined by ≥20% from 2000 to 2019.

Results

Eleven disease categories achieved a ≥20% mortality reduction, including the leading causes of death in the United States (heart disease, stroke, cancer) and 2 infectious diseases. Seven of the 11 "success" conditions were forms of cancer, showing progress in screening, early diagnosis, treatment, and cure. A cautionary note is warranted for conditions with increasing cause-specific mortality, such as brain diseases, suicide, drug overdose, accidental deaths, and liver disease.

Conclusions

The impact of research innovation translated into prevention and medical care is clearer with each passing decade. Similar strategies that prioritize behavioral health will be needed to reverse conditions with worsening mortality. Successful public health strategies have continued to reduce mortality from somatic "below-the-neck" causes, but parallel strategies are needed to address mental health, substance use, health behaviors, and healthy aging.

Read PDF

Similar papers

Open access Aug 2026

Trends and projections in cause-specific mortality among patients with colorectal cancer in the United States, 1999–2040

Despite declining overall CRC mortality, recent increases were observed in several metastatic and noncancer contributing conditions, and model-based projections indicate that overall lung metastasis mortality will continue to increase through 2040, whereas liver metastasis mortality will peak in 2028 and subsequently d...

Zi-Chen He, Ya-Dong Chen, Yu-Xing Hu et al. · 0 citations
Review Open access Sep 2026

US Life Expectancy and Increasing Mortality Rates: An Analysis of the Crisis.

Policy Points US life expectancy is shorter than in other high-income countries and the gap has widened dramatically over time, driven in particular by rising mortality rates that threaten the probability that youth can survive to middle age, or even adulthood. Policy priorities to address this crisis include efforts t...

Steven H. Woolf · 0 citations
Conference Open access 2026

Regional mortality inequalities and causes of death in the Republic of Moldova, 2014-2023

This study examines the regional disparities in overall and cause-specific mortality trends in the Republic of Moldova between 2014 and 2023. Depersonalised individual death records and official post-censal population estimates were used to construct life tables and age-standardised death rates for major causes of deat...

Olga Penina · 0 citations
Open access Sep 2026

Cardiomyopathy-related mortality in the United States, 1999 to 2023

Cardiovascular disease remains a major global public health burden. In recent years, advances in cardiac imaging and molecular genetics have renewed clinical attention to the diagnosis, treatment, and prevention of cardiomyopathies. However, a comprehensive quantitative assessment of the overall mortality burden associ...

Hui Liu, Yu Qian, Fa-Wang Du et al. · 0 citations
Review Open access Aug 2026

Sicker at all ages? Two decades of changing disease histories and mortality in the United States.

BACKGROUND Stagnating cardiovascular disease mortality and rising drug- and suicide-related deaths are key drivers of stalled US mortality improvements. However, prior research has largely overlooked disease histories preceding death, despite increasing multimorbidity. We examined changes in disease-history profiles in...

M. Ebeling, Neil K. Mehta, Leah Abrams et al. · 0 citations
Open access Sep 2026

Excess hypertension-related mortality among cancer patients in the United States: a SEER-based study

Cancer remains a leading cause of mortality globally, while hypertension is the primary contributor to cardiovascular disease and premature death. These conditions frequently coexist; hypertension may precede cancer due to shared risk factors or arise during or after cancer treatment, partly as a result of the hypert...

Bahaa Mali, Ali Mali, Alaa Mali et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.